NASDAQ: CDT - Conduit Pharmaceuticals Inc.

Yield per half year: +678.57%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Conduit Pharmaceuticals Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2023-09-25
ISIN US20678X1063
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.conduitpharma.com
Цена ао 1.01
Change price per day: 0% (1.09)
Change price per week: +0.9259% (1.08)
Change price per month: -33.13% (1.63)
Change price per 3 month: +1 374.97% (0.0739)
Change price per half year: +678.57% (0.14)
Change price per year: -65.51% (3.16)
Change price per year to date: +1 561.59% (0.0656)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV -719.05 0
P/E 0 0
EV/EBITDA -58.5 0
Total: 0.75

Efficiency

Title Value Grade
ROA, % -7.41 0
ROE, % 117.07 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1771 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -88 0
Yield EPS, % -84.27 0
Total: 2
More

Institutions Volume Share, %
Bank of Montreal/Can/ 10000 0.01
Kepos Capital LP 1500 0
Wells Fargo & Company 72 0
Morgan Stanley 25 0

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Micro-Cap ETF 0.00079 17.09 1.54048
iShares Russell 2000 Growth ETF 0.00012 38.04 0.6026
027.571.07



Head Job title Payment Year of birth
Dr. David Joszef Tapolczay CEO & Director 419.8k 1959 (66 years)
Dr. Joanne M. Holland Chief Scientific Officer N/A 1975 (50 years)
Mr. James Bligh Interim CFO & Director 1988 (37 years)
Mr. Bill Begien Senior VP of Investor Relations

Address: United States, San Diego. CA, 4995 Murphy Canyon Road - open in Google maps, open in Yandex maps
Website: https://www.conduitpharma.com